Amphix Bio, Inc. — Form D

Amphix Bio, Inc. of CHICAGO, IL, a company, filed a Form D exempt-offering notice with the SEC on 2025-12-19. The offering totals $12.5M, of which $10.3M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2025-12-19
• Form: D
• Accession: 0002101704-25-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $12.5M
• Amount sold: $10.3M
• Remaining: $2.2M
• Investors: 9
• Date of first sale: 2025-12-04
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-567448

Issuer

• Name: Amphix Bio, Inc.
• CIK: 0002101704
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 400 N. ABERDEEN ST., CHICAGO, IL, 60642
• Phone: 720-840-7327

Officers, directors & promoters (7)

More

• CIK 2101704 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search